About Chimeric BioScience Consulting (CBC)
CBC provides best in class scientific solutions for our customers' therapeutic development so they can best provide medicines to patients that need them.
We work hard to understand our pharmaceutical customer's challenges and offer optimal solutions to address their critical needs. CBC is uniquely positioned to address our customers needs by combining the our partner software and content offerings along with a wide array of complementary services.
Tristan Gill CEO and Founder
Tristan Gill is currently the CEO and Founder of CBC. Prior to founding CBC Tristan has 25 years of experience in top labs and companies including Cold Spring Harbor Laboratory, California Institute of Technology, Paracel a subsidiary of Celera Genomics, Rossetta BioSoftware a subsidiary of Merck & Co., Ingenuity now part of Qiagen, Bejing Genomics Institute (BGI), and Clarivate Analytics formerly Thomson Reuters. Tristan's success is attributed to his 3 principles: Understand the science and business of discovering and developing drugs, understand the customers unique needs and challenges and problem solve as a trusted partner to come up with an optimal solution.
